An intact NF-κB signaling pathway is required for maintenance of mature B cell subsets

Molecular Immunology

Volumn 36, Issue 3, 1999, Pages 187-195

  Bendall, Heather H ^a   Sikes, Michael L ^a   Ballard, Dean W ^a   Oltz, Eugene M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B cell development; B cell homeostasis; B cell receptor signaling; NF B Rel transcription factors; Transgenic mice

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL DEATH; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION; HOMEOSTASIS; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; B-LYMPHOCYTE SUBSETS; BONE MARROW; CELL DIFFERENTIATION; CELLS, CULTURED; DNA-BINDING PROTEINS; I-KAPPA B PROTEINS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; NF-KAPPA B; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; SPLEEN;

ANIMALIA; MUS MUSCULUS;

EID: 0033044091     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(99)00031-0     Document Type: Article

References (33)

1. Baeuerle P.A., Baltimore D. NF-kappa B: ten years after. Cell. 87:1996;13-20.
2. Baldwin A. The NF-kappa B and I kappa B proteins: new discoveries and insights. Ann. Rev. Immunol. 14:1996;649-681.
3. Ballard D.W., Walker W.H., Doerre S., Sista P., Molitor J.A., Dixon E.P., Peffer N.E., Hannink M., Greene W.C. The v-rel oncogene encodes a kappa B enhancer-binding protein that inhibits NF-kappa B function. Cell. 63:1990;803-814.
4. Bendall H.H., Scherer D.C., Edson C.R., Ballard D.W., Oltz E.M. Transcription factor NF kappa B regulates inducible Oct 2 gene expression in precursor B lymphocytes. J. Biol. Chem. 272:1997;28826-28828.
5. Boothby M., Liou H-C., Glimcher L.H. Differences in DNA sequence specificity among MHC class II X box binding proteins. J. Immunol. 142:1989;1005-1014.
6. Boothby M.R., Mora A.L., Scherer D.C., Brockman J.A., Ballard D.W. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of Nuclear Factor (NF)-kappaB. J. Exp. Med. 185:1997;1897-1907.
7. Brockman J.A., Scherer D.C., Hall S.M., McKinsey T.A., Qi X., Lee W.Y., Ballard D.W. Coupling of a signal-response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol. Cell. Biol. 15:1995;2809-2818.
8. Bushdid P.B., Brantley D.M., Yull F.E., Blaeuer G.L., Hoffman L.H., Niswander L., Kerr L.D. Inhibition of NF-kappaB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis. Nature. 392:1998;615-618.
9. Chen Z., Hagler J., Palombella V., Melandri F., Scherer D., Ballard D., Maniatis T. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev. 9:1995;1586-1597.
10. Chu Z.L., McKinsey T.A., Liu L., Malim M.H., Ballard D.W. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc. Natl. Acad. Sci. USA. 94:1997;10057-10062.
11. Corcoran L.M., Karvelas M., Nossal G.J., Ye Z.S., Jacks T., Baltimore D. Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. Genes Dev. 7:1993;570-582.
12. Dildrop R., Ma A., Zimmerman K., Hsu E., Tesfaye A., DePinho R., Alt F.W. IgH enhancer-mediated deregulation of N-myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c-myc expression. EMBO J. 8:1989;1121-1128.
13. Doi T.S., Takahashi T., Taguchi O., Azuma T., Obata Y. NF-kappa B Rel A-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 185:1997;953-961.
14. Franzoso G., Carlson L., Xing L., Poljak L., Shores E.W., Brown K.D., Leonardi A., Tran T., Boyce B.F., Siebenlist U. Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev. 11:1997;3482-3496.
15. Ganchi P.A., Sun S.C., Greene W.C., Ballard D.W. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding. Mol. Cell. Biol. 12:1992;1339-1352.
16. Grilli M., Jason J.S., Lenardo M. NF-kappa B and rel-participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1993;1-62.
17. Grumont R.J., Rourke I.J., O'Reilly L.A., Strasser A., Miyake K., Sha W., Gerondakis S. B lymphocytes differentially use the Rel and Nuclear Factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J. Exp. Med. 187:1998;663-674.
18. Hardy R.R., Carmack C.E., Shinton S.A., Kemp J.D., Hayakawa K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173:1991;1213-1225.
19. Healy J.I., Dolmetsch R.E., Timmerman L.A., Cyster J.G., Thomas M.L., Crabtree G.R., Lewis R.S., Goodnow C.C. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity. 6:1997;419-428.
20. Horwitz B.H., Scott M.L., Cherry S.R., Bronson R.T., Baltimore D. Failure of Lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells. Immunity. 6:1997;765-772.
21. Jenuwein T., Grosschedl T. Complex pattern of immunoglobulin mu gene expression in normal and transgenic mice: nonoverlapping regulatory sequences govern distinct tissue specifities. Genes Dev. 5:1991;932-943.
22. Khan W.N., Alt F.W., Gerstein R.M., Malynn B.A., Larsson I., Rathbun G., Davidson L., Muller S., Kantor A.B., Herzenberg L.A., Rosen F.S., Sideras P. Defective B cell development and function in Btk-deficient mice. Immunity. 3:1995;283-299.
23. Kontgen F., Grumont R.J., Strasser A., Metcalf D., Li R., Tarlinton D., Gerondakis S. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1995;1965-1977.
24. Lam K-P., Kuhn R., Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targetting results in rapid cell death. Cell. 90:1997;1073-1083.
25. Liou H.C., Sha W.C., Scott M.L., Baltimore D. Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation. Mol. Cell. Biol. 14:1994;5349-5359.
26. Miyamoto S., Seufzer B.J., Shumway S.D. Novel I kappa B alpha proteolytic pathway in WEHI231 immature B cells. Mol. Cell. Biol. 18:1998;19-29.
27. Rajewsky K. Clonal selection and learning in the antibody system. Nature. 381:1996;751-758.
28. Scherer D., Brockman J., Bendall H., Zhang G., Ballard D., Oltz E. Corepression of RelA and c-Rel inhibits immunoglobulin kappa gene transcription and rearrangement in pre-B lymphocytes. Immunity. 5:1996;563-574.
29. Schubart D.B., Rolink A., Kosco-Vilbois M.H., Botteri F., Matthias P. B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation. Nature. 383:1996;538-542.
30. Sha W.C., Liou H.C., Tuomanen E.I., Baltimore D. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell. 80:1995;321-330.
31. Shaffer A.L., Peng A., Schlissel M.S. In vivo occupancy of the kappa light chain enhancers in primary pro- and pre-B cells: A model for kappa locus activation. Immunity. 6:1997;131-143.
32. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., Baldwin A.S. NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 281:1998;1680-1683.
33. Wu M., Lee H., Bellas R.E., Schauer S.L., Arsura M., Katz D., Fitzgerald M.J., Rothstein T.L., Scherr D.H., Sonenshein G.E. Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J. 15:1996;4682-4690.